Skip to main content
Erschienen in: Wiener klinische Wochenschrift 15-16/2012

01.08.2012 | short report

Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock

verfasst von: Martin Balik, Jan Rulisek, Pavel Leden, Michal Zakharchenko, Michal Otahal, Hana Bartakova, Josef Korinek

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2012

Einloggen, um Zugang zu erhalten

Summary

Background

Betablockade has been shown to have cardioprotective effects in patients under perioperative stress. Besides animal model of septic shock and a small cohort of septic patients, these benefits have not been studied in septic shock patients who require norepinephrine administration.

Methods

After correction of preload, an esmolol bolus (0.2–0.5 mg/kg) followed by continuous 24 h infusion was administered in septic patients with sinus or supraventricular tachycardia (HR > 120/min). Exclusion criteria were severe LV systolic dysfunction, atrioventricular blockade and norepinephrine infusion at rates over 0.5 mg/kg/min. Monitoring with echocardiography and pulmonary artery catheter before, at 2, 6, 12, 24 h following the start and 6 h after ceasing of the esmolol drip. Patients were maintained normovolemic throughout the study and adjustments of concomitant norepinephrine infusion rates were made as required.

Results

Ten septic patients (mean age 54.4 ± 18.7), APACHE II 21.5 ± 6.2, CRP 275 ± 78 mg/l, procalcitonin 14.5 ± 10.1 mg/l, were given esmolol drip of 212.5 ± 63.5 mg/h at start to 272.5 ± 89.5 mg/h at 24 h. Heart rate decreased from mean 142 ± 11/min to 112 ± 9/min (p < 0.001) with parallel insignificant reduction of cardiac index (4.94 ± 0.76 to 4.35 ± 0.72 l/min/m2). Stroke volume insignificantly increased from 67.1 ± 16.3 ml to 72.9 ± 15.3 ml. No parallel change of pulmonary artery wedge pressure was observed (15.9 ± 3.2 to 15.0 ±  2.4 mmHg) as well as no significant changes of norepinephrine infusion (0.13 ±  0.17 to 0.17 ± 0.19 mg/kg/min), DO2, VO2, OER or arterial lactate.

Conclusions

Saving the heart 30 beats/min did not demonstrate adverse impact on global haemodynamics in rates above 110/min. Using well titratable betablocker seems to be safe and cardioprotective in septic shock patients with high cardiac output.
Literatur
1.
Zurück zum Zitat Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126(2):534–9.PubMedCrossRef Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126(2):534–9.PubMedCrossRef
2.
Zurück zum Zitat Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med. 2010;36(11):1882–9.PubMedCrossRef Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med. 2010;36(11):1882–9.PubMedCrossRef
3.
Zurück zum Zitat Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Critical Care, 2010;14(4):R142.PubMedCrossRef Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Critical Care, 2010;14(4):R142.PubMedCrossRef
4.
Zurück zum Zitat Jensen BC, O’Connel TD, Simpson PC. Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol. 2011;51(4):518–28.PubMedCrossRef Jensen BC, O’Connel TD, Simpson PC. Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol. 2011;51(4):518–28.PubMedCrossRef
5.
Zurück zum Zitat Schmidt H, Muller-Werdan U, Hoffman T, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005;33(9)1994–2002.PubMedCrossRef Schmidt H, Muller-Werdan U, Hoffman T, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005;33(9)1994–2002.PubMedCrossRef
6.
Zurück zum Zitat Annane D, Trabold F, Sharshar T, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160(2):458–65.PubMed Annane D, Trabold F, Sharshar T, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160(2):458–65.PubMed
7.
Zurück zum Zitat Cariou A, Pinsky MR, Monchi M, et al. Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med. 2008;34(5):917–22.PubMedCrossRef Cariou A, Pinsky MR, Monchi M, et al. Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med. 2008;34(5):917–22.PubMedCrossRef
8.
Zurück zum Zitat Chung CS, Kovacs SJ. Consequences of increasing heart rate on deceleration time, the velocity-time integral, and E/A. Am J Cardiol. 2006;97(1):130–6.PubMedCrossRef Chung CS, Kovacs SJ. Consequences of increasing heart rate on deceleration time, the velocity-time integral, and E/A. Am J Cardiol. 2006;97(1):130–6.PubMedCrossRef
9.
Zurück zum Zitat Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35(6):1599–608.PubMedCrossRef Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35(6):1599–608.PubMedCrossRef
10.
Zurück zum Zitat Aboab J, Sebille V, Jourdain M, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med. 2011;37(8):1344–51.PubMedCrossRef Aboab J, Sebille V, Jourdain M, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med. 2011;37(8):1344–51.PubMedCrossRef
11.
Zurück zum Zitat Ackland GL, Yao ST, Rudiger A, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010;38(2):388–94.PubMedCrossRef Ackland GL, Yao ST, Rudiger A, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010;38(2):388–94.PubMedCrossRef
12.
Zurück zum Zitat Hagiwara S, Iwasaka H, Maeda H, Noguchi T. Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 2009;31(5):515–20.PubMedCrossRef Hagiwara S, Iwasaka H, Maeda H, Noguchi T. Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 2009;31(5):515–20.PubMedCrossRef
13.
Zurück zum Zitat Suzuki T, Morisaki H, Serita R, et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005;33(10):2294–301.PubMedCrossRef Suzuki T, Morisaki H, Serita R, et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005;33(10):2294–301.PubMedCrossRef
14.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions Conference. Crit Care Med. 2003;31(4):1250–6.CrossRef Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions Conference. Crit Care Med. 2003;31(4):1250–6.CrossRef
15.
Zurück zum Zitat Antman EM, Selwyn AP, Braunwald E, Loscalzo J. Ischaemic heart disease. In: Fauci AS, Braunwald E, et al. editors. Harrison’s principles of internal medicine. New York: McGraw Hill, 2008. p. 1514–27. Antman EM, Selwyn AP, Braunwald E, Loscalzo J. Ischaemic heart disease. In: Fauci AS, Braunwald E, et al. editors. Harrison’s principles of internal medicine. New York: McGraw Hill, 2008. p. 1514–27.
16.
Zurück zum Zitat Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med. 1999;341(24):1789–94.PubMedCrossRef Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med. 1999;341(24):1789–94.PubMedCrossRef
17.
Zurück zum Zitat Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701–6.PubMedCrossRef Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701–6.PubMedCrossRef
18.
Metadaten
Titel
Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock
verfasst von
Martin Balik
Jan Rulisek
Pavel Leden
Michal Zakharchenko
Michal Otahal
Hana Bartakova
Josef Korinek
Publikationsdatum
01.08.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0209-y

Weitere Artikel der Ausgabe 15-16/2012

Wiener klinische Wochenschrift 15-16/2012 Zur Ausgabe